We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
RIXONFYA rituximab (rch) 500 mg/50 mL concentrated injection vial, Sandoz Pty Ltd, CON-298
Product name
RIXONFYA rituximab (rch) 500 mg/50 mL concentrated injection vial
Sponsor name
Sandoz Pty Ltd
ARTG details
- 309670
Consent start
Consent no.
CON-298
Duration
Permanent exemption.
Standard
Paragraph 8(1)(n) of Therapeutic Goods Order No 91-Standard for labels of prescription and related medicines.
Non-compliance with standard
The vial labels do not include a machine readable code which complies with that
defined in Therapeutic Goods Order No 91 - Standard for labels of prescription
and related medicines.
Conditions imposed
This consent applies only toRIXVYDA rituximab (rch) concentrated injection vial
containing 100mg/10mLRIXVYDA rituximab (rch) concentrated injection vial
containing 500mg/50mLRIXONFYA rituximab (rch) concentrated injection vial
containing 100mg/10mLRIXONFYA rituximab (rch) concentrated injection vial
containing 500mg/50mL
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines